FRANCIOSO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 5.235
AS - Asia 1.168
EU - Europa 744
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 26
OC - Oceania 4
Totale 7.569
Nazione #
US - Stati Uniti d'America 5.160
SG - Singapore 529
CN - Cina 213
BR - Brasile 209
IT - Italia 171
RU - Federazione Russa 123
VN - Vietnam 117
HK - Hong Kong 95
DE - Germania 81
SE - Svezia 70
IE - Irlanda 55
FR - Francia 48
BD - Bangladesh 47
GB - Regno Unito 40
JP - Giappone 36
UA - Ucraina 36
CA - Canada 33
FI - Finlandia 31
IN - India 30
PL - Polonia 23
KR - Corea 20
AR - Argentina 18
MX - Messico 16
ES - Italia 14
TR - Turchia 12
AT - Austria 11
JM - Giamaica 11
NL - Olanda 11
ID - Indonesia 9
IQ - Iraq 9
ZA - Sudafrica 7
EC - Ecuador 6
EG - Egitto 6
IR - Iran 6
BE - Belgio 5
CR - Costa Rica 5
NG - Nigeria 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
CO - Colombia 4
CZ - Repubblica Ceca 4
IL - Israele 4
LT - Lituania 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BB - Barbados 2
KH - Cambogia 2
MA - Marocco 2
MN - Mongolia 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LC - Santa Lucia 1
LV - Lettonia 1
PA - Panama 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.429
Città #
Wilmington 1.138
Houston 1.026
Woodbridge 779
Singapore 287
Ashburn 206
San Jose 196
Fairfield 138
Chandler 136
Council Bluffs 90
Hong Kong 89
Beijing 87
Ann Arbor 78
Los Angeles 71
Seattle 70
Rome 69
New York 67
Cambridge 54
Santa Clara 49
Dublin 48
Ho Chi Minh City 47
The Dalles 40
Tokyo 35
Denver 31
Jacksonville 30
Medford 30
Hanoi 24
Buffalo 23
Dallas 23
São Paulo 23
Munich 22
Dearborn 19
Helsinki 16
Montreal 15
Nuremberg 15
Engelhard 14
Lauterbourg 14
Lawrence 14
Moscow 14
Orem 13
Brooklyn 12
Palo Alto 12
Phoenix 12
Warsaw 11
Atlanta 10
Chicago 9
Frankfurt am Main 9
Boardman 8
Redondo Beach 8
Stockholm 8
Kingston 7
Menlo Park 7
Mexico City 7
North Bergen 7
Redwood City 7
Suzhou 7
Naples 6
Philadelphia 6
San Diego 6
San Francisco 6
Seoul 6
Turku 6
Brussels 5
Charlotte 5
Chennai 5
Jakarta 5
Johannesburg 5
Las Vegas 5
London 5
Paris 5
Poplar 5
Rio de Janeiro 5
San José 5
St. George 5
Zhengzhou 5
Chandigarh 4
Colorado Springs 4
Columbus 4
Curitiba 4
Doha 4
Kunming 4
La Veta 4
Lorton 4
Miami 4
Mumbai 4
Norwalk 4
Palermo 4
Queens 4
Reading 4
Salt Lake City 4
Washington 4
Amsterdam 3
Baghdad 3
Biên Hòa 3
Bogotá 3
Bologna 3
Brno 3
Capurso 3
Caruaru 3
Caxias do Sul 3
Da Nang 3
Totale 5.476
Nome #
Recurrence of insulin resistant metabolic syndrome following liver transplantation 522
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 514
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 502
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial 501
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 490
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 489
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients 467
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. 377
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 321
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 320
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 230
A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? 221
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 207
Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): longterm results from a single-center 137-patient cohort prospective study 187
Repeated transarterial chemoembolization with degradable starch microspheres (DSMs-TACE) of unresectable hepatocellular carcinoma: A prospective pilot study 164
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 124
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 107
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 103
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 99
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 98
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 97
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 93
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 90
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 89
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 88
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 85
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 85
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 80
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 76
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 76
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 76
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 73
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 66
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 66
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 64
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 47
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 45
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA 43
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 37
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. 34
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 34
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide 29
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 29
Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity 24
Totale 7.569
Categoria #
all - tutte 22.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 0 0 0 9 4 16 18 9 13 24 13 45
2022/2023325 22 38 36 43 33 62 22 17 31 3 11 7
2023/2024213 34 8 7 2 9 53 0 5 8 53 1 33
2024/2025734 18 131 57 39 41 68 77 40 80 64 53 66
2025/20261.846 207 72 158 188 163 81 221 188 238 162 99 69
2026/2027644 110 93 310 131 0 0 0 0 0 0 0 0
Totale 7.569